On the other hand, the capability of Nanog-C and CD2 in promoting open chromatin formation might act as an additional positive effect to enhance genotoxic therapy-induced cancer cell death since open chromatins display higher sensitivity to DNA damages than condensed counterparts (Supplementary Fig. S7e) [89, 90]. Here, CD2 is linked to cancer.